[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

HK1133905A1 - Method for cloning cognate antibodies - Google Patents

Method for cloning cognate antibodies

Info

Publication number
HK1133905A1
HK1133905A1 HK10101773.9A HK10101773A HK1133905A1 HK 1133905 A1 HK1133905 A1 HK 1133905A1 HK 10101773 A HK10101773 A HK 10101773A HK 1133905 A1 HK1133905 A1 HK 1133905A1
Authority
HK
Hong Kong
Prior art keywords
linking
procedure
generation
methods
relates
Prior art date
Application number
HK10101773.9A
Other languages
English (en)
Inventor
Per-Johan Meijer
Lars Soegaard Nielsen
Jesper Kastrup
Original Assignee
Symphogen As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=38561767&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HK1133905(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Symphogen As filed Critical Symphogen As
Publication of HK1133905A1 publication Critical patent/HK1133905A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1034—Isolating an individual clone by screening libraries
    • C12N15/1093—General methods of preparing gene libraries, not provided for in other subgroups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/005—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies constructed by phage libraries
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1267—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria
    • C07K16/1282—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria from Clostridium (G)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2863—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against receptors for growth factors, growth regulators
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844—Nucleic acid amplification reactions
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/73—Inducing cell death, e.g. apoptosis, necrosis or inhibition of cell proliferation
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/76—Antagonist effect on antigen, e.g. neutralization or inhibition of binding
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2537/00—Reactions characterised by the reaction format or use of a specific feature
    • C12Q2537/10—Reactions characterised by the reaction format or use of a specific feature the purpose or use of
    • C12Q2537/143—Multiplexing, i.e. use of multiple primers or probes in a single reaction, usually for simultaneously analyse of multiple analysis

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Virology (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Plant Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
HK10101773.9A 2007-03-01 2010-02-19 Method for cloning cognate antibodies HK1133905A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DKPA200700316 2007-03-01
US90477207P 2007-03-05 2007-03-05
PCT/DK2008/050048 WO2008104184A2 (fr) 2007-03-01 2008-02-27 Procédé de clonage d'anticorps apparentés

Publications (1)

Publication Number Publication Date
HK1133905A1 true HK1133905A1 (en) 2010-04-09

Family

ID=38561767

Family Applications (1)

Application Number Title Priority Date Filing Date
HK10101773.9A HK1133905A1 (en) 2007-03-01 2010-02-19 Method for cloning cognate antibodies

Country Status (24)

Country Link
US (2) US8283294B2 (fr)
EP (1) EP2121920B1 (fr)
JP (1) JP5669397B2 (fr)
KR (1) KR20090118993A (fr)
CN (1) CN101622346A (fr)
AT (1) ATE521704T1 (fr)
AU (1) AU2008221119B2 (fr)
BR (1) BRPI0808171A2 (fr)
CA (1) CA2677771A1 (fr)
CY (1) CY1112664T1 (fr)
DK (1) DK2121920T3 (fr)
ES (1) ES2369946T3 (fr)
HK (1) HK1133905A1 (fr)
HR (1) HRP20110686T1 (fr)
IL (1) IL199773A0 (fr)
MX (1) MX2009008908A (fr)
NZ (1) NZ578851A (fr)
PL (1) PL2121920T3 (fr)
PT (1) PT2121920E (fr)
RU (1) RU2459868C2 (fr)
SI (1) SI2121920T1 (fr)
TW (1) TW200911986A (fr)
WO (1) WO2008104184A2 (fr)
ZA (1) ZA200905831B (fr)

Families Citing this family (68)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0808551B1 (pt) * 2007-03-01 2022-04-05 Symphogen A/S Composições de anticorpo para o receptor do fator de crescimento antiepidérmico recombinante, molécula de ligação bi-específica e composição farmacêutica que os compreende
JP2008289483A (ja) * 2007-05-25 2008-12-04 Symphogen As 真核生物系において発現可能な形質転換体のスクリーニング
DE102007037215A1 (de) * 2007-08-07 2009-02-12 Robert Bosch Gmbh Stellorgan
WO2010000864A1 (fr) * 2008-07-04 2010-01-07 Novo Nordisk A/S Procédé de production d'anticorps monoclonaux
WO2010022738A1 (fr) * 2008-08-29 2010-03-04 Symphogen A/S Méthode de clonage d’anticorps d’origine aviaire
CA2732856C (fr) 2008-08-29 2018-08-28 Symphogen A/S Traitement contre le cancer comportant une combinaison de deux anticorps recepteurs de facteur de croissance anti-epidermiques
US9506119B2 (en) 2008-11-07 2016-11-29 Adaptive Biotechnologies Corp. Method of sequence determination using sequence tags
US9365901B2 (en) 2008-11-07 2016-06-14 Adaptive Biotechnologies Corp. Monitoring immunoglobulin heavy chain evolution in B-cell acute lymphoblastic leukemia
US8691510B2 (en) * 2008-11-07 2014-04-08 Sequenta, Inc. Sequence analysis of complex amplicons
EP3699296A1 (fr) 2008-11-07 2020-08-26 Adaptive Biotechnologies Corporation Procédés de surveillance de maladies par l'analyse de séquences
US8748103B2 (en) 2008-11-07 2014-06-10 Sequenta, Inc. Monitoring health and disease status using clonotype profiles
US9528160B2 (en) 2008-11-07 2016-12-27 Adaptive Biotechnolgies Corp. Rare clonotypes and uses thereof
US8628927B2 (en) 2008-11-07 2014-01-14 Sequenta, Inc. Monitoring health and disease status using clonotype profiles
WO2010083456A1 (fr) 2009-01-15 2010-07-22 Imdaptive Inc. Profilage d'immunité adaptative et méthodes de génération d'anticorps monoclonaux
US9079942B2 (en) * 2009-02-09 2015-07-14 Epitomics, Inc. CDR-anchored amplification method
ES2570460T3 (es) * 2009-02-20 2016-05-18 Hoffmann La Roche Método de obtención de ácido nucleico que codifica inmunoglobulina
US20100317539A1 (en) * 2009-06-12 2010-12-16 Guo-Liang Yu Library of Engineered-Antibody Producing Cells
KR20140146180A (ko) 2009-06-25 2014-12-24 프레드 헛친슨 켄서 리서치 센터 적응 면역의 측정방법
US8293483B2 (en) 2009-09-11 2012-10-23 Epitomics, Inc. Method for identifying lineage-related antibodies
US9043160B1 (en) 2009-11-09 2015-05-26 Sequenta, Inc. Method of determining clonotypes and clonotype profiles
DE102010037622B4 (de) * 2010-09-17 2012-07-12 Lophius Biosciences Gmbh Verfahren zum Nachweis, Differenzieren und Quantifizieren von T-Zellpopulationen mittels der Reverse Transkription quantitativen Real-Time PCR (RT-qPCR) Technologie
EP2625295B1 (fr) * 2010-10-08 2019-03-13 President and Fellows of Harvard College Séquençage immunitaire à haut débit
US9155802B2 (en) 2010-11-01 2015-10-13 Symphogen A/S Pan-HER antibody composition
EP2647704B1 (fr) * 2010-12-01 2017-11-01 Mitsubishi Tanabe Pharma Corporation Construction polynucléotidique capable de présenter le fab dans un système de traduction acellulaire, et procédé de fabrication et de criblage de fab à l'aide de celle-ci
US20130316358A1 (en) * 2011-01-31 2013-11-28 Yeda Research And Development Co. Ltd. Methods of diagnosing disease using overlap extension pcr
EP3418380B1 (fr) * 2011-04-28 2022-05-25 The Board of Trustees of the Leland Stanford Junior University Identification de polynucléotides associés à un échantillon
US10385475B2 (en) 2011-09-12 2019-08-20 Adaptive Biotechnologies Corp. Random array sequencing of low-complexity libraries
WO2013041617A1 (fr) 2011-09-21 2013-03-28 F. Hoffmann-La Roche Ag Procédé d'obtention de fragments fab à partir de cellules uniques productrices d'anticorps par pcr multiplexe en combinaison avec des sondes taqman
WO2013059725A1 (fr) 2011-10-21 2013-04-25 Adaptive Biotechnologies Corporation Quantification de génomes de cellules immunitaires adaptatives dans un mélange complexe de cellules
EP2788509B1 (fr) 2011-12-09 2018-07-11 Adaptive Biotechnologies Corporation Diagnostic des malignités lymphoïdes et détection de maladie résiduelle minimale
US9499865B2 (en) 2011-12-13 2016-11-22 Adaptive Biotechnologies Corp. Detection and measurement of tissue-infiltrating lymphocytes
EP2626433B1 (fr) 2012-02-09 2017-04-12 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Procédé pour lier les acides nucléiques dans un microsome provenant du réticulum endoplasmique
US10077478B2 (en) 2012-03-05 2018-09-18 Adaptive Biotechnologies Corp. Determining paired immune receptor chains from frequency matched subunits
EP2844675B1 (fr) 2012-05-02 2019-01-02 Symphogen A/S Compositions d'anticorps pan-her humanisés
US9150905B2 (en) 2012-05-08 2015-10-06 Adaptive Biotechnologies Corporation Compositions and method for measuring and calibrating amplification bias in multiplexed PCR reactions
CA2875695C (fr) * 2012-06-15 2022-11-15 The Board Of Regents Of The University Of Texas System Sequencage a haut debit de multiples transcrits d'une cellule unique
WO2014055561A1 (fr) 2012-10-01 2014-04-10 Adaptive Biotechnologies Corporation Évaluation de l'immunocompétence par la diversité des récepteurs de l'immunité adaptative et la caractérisation de la clonalité
CN103074349B (zh) * 2012-11-07 2014-10-15 杭州鸿运华宁生物医药工程有限公司 巢式一步法rt-pcr从单个b细胞扩增鼠源抗体重链和轻链可变区基因全序列的方法
CA2903025A1 (fr) * 2013-03-11 2014-10-09 Regeneron Pharmaceuticals, Inc. Souris transgeniques exprimant des molecules de classe ii de complexe majeur d'histocompatibilite (cmh) chimerique
US20160033504A1 (en) * 2013-03-15 2016-02-04 Alder Biopharmaceuticals, Inc. Protocol for identifying and isolating antigen-specific b cells and producing antibodies to desired antigens
KR20160015286A (ko) 2013-05-31 2016-02-12 제넨테크, 인크. 항-세포벽 테이코산 항체 및 접합체
PL3004162T3 (pl) 2013-05-31 2020-07-27 Genentech, Inc. Przeciwciała i koniugaty przeciwko kwasowi tejchojowemu ściany komórkowej
US9803002B2 (en) 2013-05-31 2017-10-31 Genentench, Inc. Anti-wall teichoic antibodies and conjugates
US9708657B2 (en) 2013-07-01 2017-07-18 Adaptive Biotechnologies Corp. Method for generating clonotype profiles using sequence tags
EP3114240B1 (fr) 2014-03-05 2019-07-24 Adaptive Biotechnologies Corporation Procédés dans lesquels on utilise des molécules synthétiques contenant des randomères
US10066265B2 (en) 2014-04-01 2018-09-04 Adaptive Biotechnologies Corp. Determining antigen-specific t-cells
EP3132059B1 (fr) 2014-04-17 2020-01-08 Adaptive Biotechnologies Corporation Quantification de génomes de cellules de l'immunité acquise dans un mélange complexe de cellules
CA2966201A1 (fr) 2014-10-29 2016-05-06 Adaptive Biotechnologies Corp. Detection simultanee hautement multiplexee d'acides nucleiques codant pour des heterodimeres de recepteurs de l'immunite adaptative apparies a partir de nombreux echantillons
US10246701B2 (en) 2014-11-14 2019-04-02 Adaptive Biotechnologies Corp. Multiplexed digital quantitation of rearranged lymphoid receptors in a complex mixture
CA2968543C (fr) 2014-11-25 2024-04-02 Adaptive Biotechnologies Corporation Caracterisation de la reponse immunitaire adaptative a la vaccination ou a l'infection a l'aide du sequencage du repertoire immunitaire
KR20170086536A (ko) 2014-12-03 2017-07-26 제넨테크, 인크. 항-스타필로코커스 아우레우스 항체 리파마이신 접합체 및 이의 용도
AU2016222788B2 (en) 2015-02-24 2022-03-31 Adaptive Biotechnologies Corp. Methods for diagnosing infectious disease and determining HLA status using immune repertoire sequencing
US10513733B2 (en) 2015-03-23 2019-12-24 Board Of Regents, The University Of Texas System High throughout sequencing of paired VH and VL transcripts from B cells secreting antigen-specific antibodies
EP3277294B1 (fr) 2015-04-01 2024-05-15 Adaptive Biotechnologies Corp. Procédé d'identification des récepteurs de lymphocytes t spécifiques à compatibilité humaine pour une cible antigénique
EP4345107A3 (fr) * 2015-06-09 2024-06-12 Gigagen, Inc. Protéines de fusion recombinantes et bibliothèques provenant de répertoires de cellules immunitaires
US9422547B1 (en) 2015-06-09 2016-08-23 Gigagen, Inc. Recombinant fusion proteins and libraries from immune cell repertoires
HRP20221041T1 (hr) 2015-10-02 2022-11-11 Symphogen A/S Anti-pd-1 antitijela i sastavi
AU2017228468B2 (en) 2016-03-04 2019-12-05 Genentech, Inc. Process for the preparation of an antibody-rifamycin conjugate
MA45031A (fr) 2016-05-18 2019-03-27 Genmab Bv Anticorps et leurs procédés d'utilisation dans le traitement de maladies infectieuses
US10428325B1 (en) 2016-09-21 2019-10-01 Adaptive Biotechnologies Corporation Identification of antigen-specific B cell receptors
EP3541841B1 (fr) 2016-11-18 2024-09-11 Les Laboratoires Servier Anticorps anti-pd-1 et compositions
KR20240133790A (ko) * 2016-12-23 2024-09-04 비스테라, 인크. 결합 폴리펩타이드 및 이의 제조 방법
US11866785B2 (en) 2017-10-27 2024-01-09 Board Of Regents, The University Of Texas System Tumor specific antibodies and T-cell receptors and methods of identifying the same
US11254980B1 (en) 2017-11-29 2022-02-22 Adaptive Biotechnologies Corporation Methods of profiling targeted polynucleotides while mitigating sequencing depth requirements
SG11202106658XA (en) 2018-12-21 2021-07-29 Regeneron Pharma Rifamycin analogs and antibody-drug conjugates thereof
CN109972209B (zh) * 2019-01-18 2022-05-03 南开大学 基于乳液pcr的一步法将单链抗体库重排为全长抗体库的方法
EP3941491A4 (fr) 2019-03-21 2023-03-29 Gigamune, Inc. Cellules modifiées exprimant des récepteurs de lymphocytes t anti-viraux et leurs méthodes d'utilisation
CN115109794A (zh) * 2022-06-30 2022-09-27 武汉生之源生物科技股份有限公司 一种噬菌粒载体及其制备方法和应用

Family Cites Families (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4683202A (en) 1985-03-28 1987-07-28 Cetus Corporation Process for amplifying nucleic acid sequences
US5618920A (en) * 1985-11-01 1997-04-08 Xoma Corporation Modular assembly of antibody genes, antibodies prepared thereby and use
US5576195A (en) * 1985-11-01 1996-11-19 Xoma Corporation Vectors with pectate lyase signal sequence
US5906936A (en) * 1988-05-04 1999-05-25 Yeda Research And Development Co. Ltd. Endowing lymphocytes with antibody specificity
AU1457992A (en) 1991-03-01 1992-10-06 Stratagene Pcr generated dicistronic dna molecules for producing antibodies
US6277969B1 (en) * 1991-03-18 2001-08-21 New York University Anti-TNF antibodies and peptides of human tumor necrosis factor
US6284471B1 (en) * 1991-03-18 2001-09-04 New York University Medical Center Anti-TNFa antibodies and assays employing anti-TNFa antibodies
ATE175997T1 (de) 1991-08-10 1999-02-15 Medical Res Council Behandlung von zellpopulationen
ES2153379T3 (es) 1992-03-31 2001-03-01 Abbott Lab Procedimiento de reaccion de ligasa en cadena multiplex.
GB9220808D0 (en) 1992-10-02 1992-11-18 Medical Res Council Antibody genes
US6096878A (en) * 1993-05-10 2000-08-01 Japan Tobacco Inc. Human immunoglobulin VH gene segments and DNA fragments containing the same
DE69531148T2 (de) 1994-01-31 2004-04-29 Trustees Of Boston University, Boston Bibliotheken aus polyklonalen antikörpern
FR2724393A1 (fr) 1994-09-12 1996-03-15 Inst Nat Sante Rech Med Obtention d'un anticorps monoclonal recombinant humanise a partir d'un anticorps monoclonal murin, sa production en cellules d'insecte, et ses utilisations
US6111166A (en) 1994-09-19 2000-08-29 Medarex, Incorporated Transgenic mice expressing human Fcα and β receptors
US6258529B1 (en) * 1994-12-01 2001-07-10 Oravax, Inc. PCR amplification of rearranged genomic variable regions of immunoglobulin genes
US5882856A (en) * 1995-06-07 1999-03-16 Genzyme Corporation Universal primer sequence for multiplex DNA amplification
WO1998047343A2 (fr) * 1997-04-04 1998-10-29 Biosite Diagnostics, Inc. Bibliotheques polyvalentes et polyclonales
US6610293B1 (en) * 1997-06-16 2003-08-26 The Henry M. Jackson Foundation For The Advancement Of Military Medicine Opsonic and protective monoclonal and chimeric antibodies specific for lipoteichoic acid of gram positive bacteria
WO1999016904A1 (fr) 1997-09-29 1999-04-08 City Of Hope Liaison efficace de segments d'acide nucleique
IL136544A0 (en) * 1997-12-05 2001-06-14 Scripps Research Inst Humanization of murine antibody
US6194551B1 (en) * 1998-04-02 2001-02-27 Genentech, Inc. Polypeptide variants
US20020102604A1 (en) * 1999-12-08 2002-08-01 Milne Edwards Jean-Baptiste Dumas Full-length human cDNAs encoding potentially secreted proteins
ES2282256T3 (es) 2000-05-26 2007-10-16 Symphogen A/S Anticuerpos policlonales recombinantes o purificados para tratar la alergia.
IL136459A0 (en) 2000-05-30 2001-06-14 Galim Galil Immunology Ltd Antibody library
US6849259B2 (en) * 2000-06-16 2005-02-01 Symphogen A/S Polyclonal antibody composition for treating allergy
US6994963B1 (en) * 2000-07-10 2006-02-07 Ambion, Inc. Methods for recombinatorial nucleic acid synthesis
US6867021B2 (en) * 2001-02-20 2005-03-15 Board Of Trustees Of Michigan State University Multiplex RT-PCR/PCR for simultaneous detection of bovine coronavirus, bovine rotavirus, Cryptosporidium parvum, and Escherichia coli
CA2492092A1 (fr) * 2002-06-28 2004-01-08 Greg Winter Ligand
US20040067532A1 (en) * 2002-08-12 2004-04-08 Genetastix Corporation High throughput generation and affinity maturation of humanized antibody
US20060275766A1 (en) * 2003-01-07 2006-12-07 Haurum John S Method for manufacturing recombinant polyclonal proteins
KR101024443B1 (ko) * 2003-01-07 2011-03-23 심포젠 에이/에스 재조합 폴리클로날 단백질의 제조 방법
US20050090453A1 (en) * 2003-01-15 2005-04-28 Solbec Pharmaceuticals Co., Ltd. Methods of modulating IL-6
US20060228350A1 (en) * 2003-08-18 2006-10-12 Medimmune, Inc. Framework-shuffling of antibodies
RU2392324C2 (ru) * 2003-09-18 2010-06-20 Симфоген А/С Способ связывания интересующих последовательностей
TWI333977B (en) * 2003-09-18 2010-12-01 Symphogen As Method for linking sequences of interest
US7993919B2 (en) * 2003-11-19 2011-08-09 The United States Of America As Represented By The Department Of Health And Human Services Method of inducing memory B cell development and terminal differentiation
KR20070038556A (ko) 2004-07-20 2007-04-10 심포젠 에이/에스 항-ｒｈｅｓｕｓ ｄ 재조합 폴리클로날 항체 및 이의 제조방법
JP4870667B2 (ja) * 2004-07-20 2012-02-08 シムフォゲン・アクティーゼルスカブ 組換えポリクローナルタンパク質またはポリクローナル細胞株を構造上特徴付ける方法
US20060094645A1 (en) * 2004-10-06 2006-05-04 Oliver Lawless Method for defining and treating chemically-induced immune disorders using tumor necrosis factor (TFNalpha), interleukin-1 (lL-1), and interleulin-6R(lL-6R) antagonists
US8945857B2 (en) 2005-07-01 2015-02-03 John Schrader Methods of isolating cells and generating monoclonal antibodies
JP2009518320A (ja) 2005-12-05 2009-05-07 シュムフォウエン アクティーゼルスカブ 抗オルトポックスウイルス組換えポリクローナル抗体
KR20080113223A (ko) 2006-03-06 2008-12-29 심포젠 에이/에스 호흡기세포 융합 바이러스 감염 치료용 재조합 폴리클로날 항체
BRPI0808551B1 (pt) * 2007-03-01 2022-04-05 Symphogen A/S Composições de anticorpo para o receptor do fator de crescimento antiepidérmico recombinante, molécula de ligação bi-específica e composição farmacêutica que os compreende
EP2134747A2 (fr) * 2007-03-06 2009-12-23 Symphogen A/S Anticorps recombinants pour le traitement des infections au virus respiratoire syncytial
DK2152872T3 (da) * 2007-05-25 2010-12-06 Symphogen As Fremgangsmåde til fremstilling af et rekombinant polyklonalt protein
CN101821289A (zh) * 2007-09-07 2010-09-01 西福根有限公司 重组制造抗rsv抗体的方法
WO2010022738A1 (fr) * 2008-08-29 2010-03-04 Symphogen A/S Méthode de clonage d’anticorps d’origine aviaire

Also Published As

Publication number Publication date
WO2008104184A2 (fr) 2008-09-04
ATE521704T1 (de) 2011-09-15
SI2121920T1 (sl) 2011-12-30
IL199773A0 (en) 2010-04-15
DK2121920T3 (da) 2011-11-21
KR20090118993A (ko) 2009-11-18
RU2009136342A (ru) 2011-04-10
CN101622346A (zh) 2010-01-06
US20130023447A1 (en) 2013-01-24
JP5669397B2 (ja) 2015-02-12
CY1112664T1 (el) 2016-02-10
NZ578851A (en) 2011-09-30
ES2369946T3 (es) 2011-12-09
HRP20110686T1 (hr) 2011-10-31
TW200911986A (en) 2009-03-16
MX2009008908A (es) 2009-08-28
AU2008221119A1 (en) 2008-09-04
BRPI0808171A2 (pt) 2014-08-05
PL2121920T3 (pl) 2012-01-31
WO2008104184A3 (fr) 2008-10-16
EP2121920A2 (fr) 2009-11-25
CA2677771A1 (fr) 2008-09-04
AU2008221119B2 (en) 2013-11-14
PT2121920E (pt) 2011-10-03
US20080227660A1 (en) 2008-09-18
EP2121920B1 (fr) 2011-08-24
JP2010535150A (ja) 2010-11-18
US8283294B2 (en) 2012-10-09
ZA200905831B (en) 2011-02-23
RU2459868C2 (ru) 2012-08-27

Similar Documents

Publication Publication Date Title
HK1133905A1 (en) Method for cloning cognate antibodies
BRPI0917352A2 (pt) Métodos para produção de uma biblioteca de pares cognatos que compreende sequências ligadas que codificam regiões variáveis e para gerar um vetor que codifica um anticorpo quimérico com regiões de seres humanos constantes e regiões variáveis não humanas, biblioteca de vetores, e método para produção de uma biblioteca de sequências de imunoglobulina derivadas de aves
WO2010070145A3 (fr) Procédé de génération de séquences d'immunoglobulines
WO2007123744A3 (fr) Systèmes et procédés pour analyse de séquençage par synthèse
MX338063B (es) Molecula de union especifica al rsv.
WO2007136736A3 (fr) Procédés de tri et de synthèse d'acides nucléiques
WO2007058527A3 (fr) Systemes d’expression inductible
IN2012DN00403A (fr)
WO2008052101A3 (fr) Ingénierie génomique automatisée à multiplexage
WO2006081222A3 (fr) Amplification isotherme d'adn
WO2008078180A3 (fr) Matériaux et procédés pour la génération de transcrits comprenant des nucléotides modifiés
WO2009145820A3 (fr) Génération de polymérases modifiées pour une précision améliorée dans le séquençage d'une seule molécule
CL2011000442A1 (es) Secuencia de acido nucleico de locus de floracion de remolacha azucarera; polipeptido codificados por dichas secuencias, vector de expresion que comprende dichos polinucleotidos, y procedimiento para prodiucir semillas hibridas con resistencia al espigado.
MY148907A (en) Method for linking sequences of interest
WO2010039852A3 (fr) Banques d'anticorps améliorées
MX2010002463A (es) Plantas con rasgos relacionados con un rendimiento aumentado y un metodo para producirlas.
WO2008042067A3 (fr) Compositions et procédés de séquencage nucléotidique
WO2008061129A3 (fr) Procédés et compositions se rapportant à un gradient pcr thermique à écoulement continu
WO2008058282A3 (fr) Procédés et compositions pour analyse à grande échelle d'acides nucléiques par suppressions d'adn
WO2009091847A3 (fr) Compositions, procédés et systèmes pour le séquençage d'une molécule simple
AU2009209251A8 (en) Stabilized Angiopoietin-2 antibodies and uses thereof
WO2005118806A3 (fr) Procedes et compositions faisant intervenir des molecules de micro-arn
MX2009007246A (es) Plantas con rasgos relacionados con el rendimiento mejorado y un metodo para producirlas.
MX346024B (es) Optimización de solubilidad de inmuno-aglutinantes.
WO2008115632A3 (fr) Procédé de recombinaison de séquences d'adn et compositions s'y rapportant

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20150227